Skip to main content
. 2024 Sep 19;27(1):e301003. doi: 10.1136/bmjment-2024-301003

Figure 3. Results from instrumental variable (IV) analyses: effect estimates of attention-deficit/hyperactivity disorder (ADHD) medication on psychiatric comorbidities. Patients diagnosed with ADHD in Norway in 2009–2011, aged 5–18 at time of diagnosis. Coefficient plots for regressions with 95% CIs. Two-stage least squares (2SLS) estimates adjusted for patient mix.

Figure 3